Latham & Watkins

Helping Private Equity dealmaking evolve.

Network Bio operates a clinical and molecular data library focused on facilitating precision medicine for common human diseases. Its platform serves as a centralized repository for clinical and molecular data, allowing researchers to analyze patterns and correlations. This analysis can lead to the development of new treatments and diagnostic tools, thereby advancing medical research and improving patient outcomes.

Reynen Court LLC operates a platform designed to assist law firms and corporate legal departments in adopting legal technology tools, including contract analysis, discovery, and practice management. Founded in 2018 and headquartered in Amsterdam, with an additional office in Piedmont, California, Reynen Court offers a solution store that facilitates the safe deployment of third-party, cloud-based software applications. The platform features a control panel that allows users to manage subscriptions and provisioning from a single location, enhancing interoperability between various legal technology applications. By streamlining the integration of artificial intelligence and smart contracts, Reynen Court minimizes the risks associated with exposing firm or client content to multiple cloud environments, thereby promoting efficient and secure technology adoption in the legal sector.

DrizzleX Ltd develops an innovative water metering solution aimed at promoting water conservation in residential buildings lacking individual apartment meters. The company offers a platform that combines IoT micrometers with a software-as-a-service dashboard, providing real-time data on water usage. This system allows property managers and tenants to monitor consumption patterns, identify leaks, and encourage responsible water usage, ultimately leading to reductions in water bills by 20-40% or more. By empowering tenants to take control of their water consumption and offering property owners tools to manage expenses effectively, DrizzleX supports both economic and environmental sustainability. Founded in 2017 and based in Jerusalem, Israel, the company has expanded its installations across several states, including California, Nevada, Arizona, and New York.

KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California. KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.